Dyne Therapeutics, Inc. (DYN) Stock Research
Dyne Therapeutics, Inc., a clinical-stage neuromuscular disease company, focuses on discovering and developing therapeutics for neuromuscular diseases in the United States. The company is developing a portfolio of muscle disease therapeutics, including programs in myotonic dystrophy type 1; duchenne muscular dystrophy; facioscapulohumeral dystrophy; and Pompe disease, as well as rare skeletal muscle, and cardiac and metabolic muscle diseases using its FORCE platform that delivers disease-modifying therapeutics. Dyne Therapeutics, Inc. was incorporated in 2017 and is headquartered in Waltham, Massachusetts.
Latest price: 15.4 · Sector: Healthcare
Recent Insider Transactions
| Insider | Type | Date | Value |
|---|---|---|---|
| Posner Brian S | buy | 2026-10-02 | 40000 |
| Kerr Douglas | sell | 2026-09-08 | 24355.2 |
| Friedl-Naderer Johanna | sell | 2026-09-04 | 21915 |
| Cox John | sell | 2026-09-08 | 106823.04 |
| Kerr Douglas | sell | 2026-09-04 | 91190.75 |
| Friedl-Naderer Johanna | sell | 2026-09-08 | 3492.8 |
| Rhodes Jason P | sell | 2026-08-13 | 1667446.6 |
| Rhodes Jason P | sell | 2026-08-13 | 2473673 |
| Rhodes Jason P | sell | 2026-08-14 | 33991850 |
| Kerr Douglas | sell | 2026-08-13 | 40891.68 |